Home/Filings/4/0000899243-20-029976
4//SEC Filing

Rosen Oliver 4

Accession 0000899243-20-029976

CIK 0001604477other

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 6:30 PM ET

Size

5.4 KB

Accession

0000899243-20-029976

Insider Transaction Report

Form 4
Period: 2020-10-29
Rosen Oliver
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2020-10-29+10,53010,530 total
    Exercise: $16.00Exp: 2030-10-28Common Stock (10,530 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on October 29, 2021 and in 36 equal monthly installments thereafter.

Issuer

SQZ Biotechnologies Co

CIK 0001604477

Entity typeother

Related Parties

1
  • filerCIK 0001714870

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 6:30 PM ET
Size
5.4 KB